| |
|
|
|
Clearpoint Neuro Inc  
|
|
9.53 -0.4 (-0.04%) |
11-24 16:00 |
|
Open: |
10.05 |
Pre close: |
9.93 |
Target:
|
12.05
|
|
High: |
10.12 |
Low: |
9.07 |
Resistance:
|
10.32
12.05
|
|
Volume: |
180,824 |
Market Cap: |
161M |
Support:
|
7.87
6.35
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
9.43
 |
MACD |
MACD(12,26):
|
0.85 |
|
MA(20): |
7.92 |
Signal(12,26,9): |
0.69 |
|
MA(100): |
5.50 |
Stochastic Oscillator |
%K(14,3):
|
89.27  |
|
MA(250): |
4.78 |
%D(3): |
92.86 |
|
Average Volume(K) |
3-Month: |
13468
|
52-Week |
High:
|
10.32 |
|
10-Days: |
22529 |
Low: |
2.86 |
|
RSI |
RSI(14):
|
69.64 |
Change(%): |
150.8 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-222.4 |
Shares Out. (M) |
15.88 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-19.1 |
Shares Float (M) |
9.98 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
28.71 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
20.2 |
% Held by Institutions |
6.58 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.465 |
Shares Short (K) |
111 |
|
Book Value (p.s.) |
0.000 |
EBITDA (p.s.) |
-0.325 |
P/E |
0.00 |
|
Sales Per Share |
0.776 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.00 |
|
Profit Margin |
-55.55 |
Operating Cash Flow
(M) |
-5.87 |
P/S |
12.28 |
|
Operating Margin |
-43.60 |
Levered Free Cash Flow
(M) |
-2.98 |
P/CF |
-25.78 |
|
|
|
|
|
|
